Pharmacy & Prescribing
Polypharmacy, drug interactions, and prescribing safety
UK medicines regulator issues Class 4 alert for gabapentin oral solution due to particle contamination
The UK Medicines and Healthcare products Regulatory Agency has issued a Class 4 alert for Gabapentin Relonchem 50mg/ml Oral Solution…
Editor's Top Picks
Semaglutide Dosing Errors Driving Surge in Poison Control Calls, Study Shows
Poison control centres are reporting a surge in calls related to semaglutide (Ozempic, Wegovy) following the drug's approval for weight…
Submit Your Paper →
More form Pharmacy & Prescribing
The NAD⁺ Injection Boom: Miracle Anti-Ageing Fix or Unregulated Gamble?
NAD⁺ injections and infusions, along with oral "NAD boosters" like nicotinamide riboside and nicotinamide mononucleotide,…
Honey as Heart Medicine? What Happens When Marketing Outruns Evidence
The global dietary supplement market exceeded USD 177 billion in 2023, and bee-derived products are…
Too Many Pills: How Pharmacists Are Solving Medicine’s Polypharmacy Problem
Polypharmacy — patients taking multiple medications simultaneously — is a growing global challenge, especially among…
CoQ10 and Statins: What Patients on Cholesterol Medication Should Know
Statins save lives — and, as a documented side effect of how they work, lower…
Creatine for Brain Health: What the Evidence Actually Shows
Creatine's muscle-building effects are supported by robust evidence, but cognitive claims rest on a weaker,…